China Cord Blood Corporation. (CO) 6.42 $CO China Cord

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
China Cord Blood Corporation. (CO) 6.42 $CO

China Cord Blood (CO) Is Today's Strong On High Volume Stock
at The Street - Wed Apr 22, 9:06AM CDT
Trade-Ideas LLC identified China Cord Blood (CO) as a strong on high relative volume candidate
CO: 6.42 (-0.05)

28.7% Return Seen to Date on SmarTrend China Cord Blood Call (CO)
Comtex SmarTrend(R) - Tue Apr 21, 11:34AM CDT
SmarTrend identified an Uptrend for China Cord Blood (NYSE:CO) on February 4th, 2015 at $4.91. In approximately 3 months, China Cord Blood has returned 28.72% as of today's recent price of $6.32.
CO: 6.42 (-0.05)

American Eagle Outfitters and Make It Right Launch National Denim Recycling Program for Earth Day
Business Wire - Mon Apr 20, 9:38AM CDT
In honor of Earth Day, Make It Right is kicking off a partnership with leading apparel company American Eagle Outfitters to recycle used and unwanted denim into building materials for affordable homes.
AEO: 16.93 (unch), CO: 6.42 (-0.05)

China Cord Blood: Attractive Buyout Target With 22.4% Upside And Minimal Bloodletting
Jennifer Wang - at Seeking Alpha - Thu Apr 16, 1:53PM CDT

CO: 6.42 (-0.05)

17.1% Return Seen to Date on SmarTrend China Cord Blood Call (CO)
Comtex SmarTrend(R) - Tue Apr 14, 10:32AM CDT
SmarTrend identified an Uptrend for China Cord Blood (NYSE:CO) on February 4th, 2015 at $4.91. In approximately 2 months, China Cord Blood has returned 17.11% as of today's recent price of $5.75.
CO: 6.42 (-0.05)

Uptrend Call Working As China Cord Blood Stock Rises 23.0% (CO)
Comtex SmarTrend(R) - Tue Apr 07, 9:24AM CDT
SmarTrend identified an Uptrend for China Cord Blood (NYSE:CO) on February 4th, 2015 at $4.91. In approximately 2 months, China Cord Blood has returned 23.01% as of today's recent price of $6.04.
CO: 6.42 (-0.05)

Shares of CO Up 15.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Mar 30, 10:08AM CDT
SmarTrend identified an Uptrend for China Cord Blood (NYSE:CO) on February 4th, 2015 at $4.91. In approximately 2 months, China Cord Blood has returned 15.48% as of today's recent price of $5.67.
CO: 6.42 (-0.05)

BUYINS.NET: ENS, EOC, AUO, CO, IDT, DPZ Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Mar 27, 7:52AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of EnseCo Energy Services Corp (NYSE:ENS), Empresa Nacional de Electricidad SA (NYSE:EOC), AU Optronics Corp (NYSE:AUO), China Cord Blood Corp (NYSE:CO), IDT Corp (NYSE:IDT), Domino's Pizza Inc (NYSEPZ) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
AUO: 5.04 (+0.10), IDT: 17.66 (unch), DPZ: 99.80 (+0.40), CO: 6.42 (-0.05), EOC: 46.48 (-0.47), ENS: 68.26 (+0.19)

China Cord Blood (CO) Worth Watching: Stock Gains 7.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 24, 8:25AM CDT
China Cord Blood (CO) was a big mover last session, with shares rising over 7% on the day.
CHE: 122.49 (+0.25), CO: 6.42 (-0.05)

CEOs Just Can't Let Go of the Company Jet for Personal Use – Even When They Should
at The Street - Mon Mar 23, 10:59AM CDT
In times of trouble, one might think companies would be quick to squeeze the personal corporate jet perk for CEOs from their budgets. But many are holding on tight.
GE: 26.91 (+0.29), NKE: 100.15 (-0.14), UTX: 116.96 (+0.01), C: 53.10 (+0.62), CHTR: 184.88 (-1.93), WFC: 54.67 (+0.39), MHFI: 104.25 (+0.69), BA: 151.19 (-2.14), PEP: 97.28 (+0.50), CI: 130.25 (-0.45), GS: 198.32 (+1.48), IBM: 165.36 (+1.10), TGT: 81.34 (+0.09), CO: 6.42 (-0.05)

Shares of CO Up 23.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Mar 23, 9:33AM CDT
SmarTrend identified an Uptrend for China Cord Blood (NYSE:CO) on February 4th, 2015 at $4.91. In approximately 2 months, China Cord Blood has returned 23.83% as of today's recent price of $6.08.
CO: 6.42 (-0.05)

An Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital
PR Newswire - Thu Mar 19, 11:24AM CDT
The following is an open letter sent March 19, 2015 to the Board of Directors of China Cord Blood Corp (NYSE: CO) from Jayhawk Capital.
CO: 6.42 (-0.05)

China Cord Blood's (CO) CEO Tina Zheng on Q3 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 26, 12:28PM CST

CO: 6.42 (-0.05)

China Cord Blood Corp (CO) Jumps: Stock Up 9.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 20, 8:25AM CST
China Cord Blood Corp (CO) was a big mover last session, with shares rising over 9% on the day.
CO: 6.42 (-0.05), AMED: 26.07 (+0.03)

How it All Plays Out: Special Research on Global Defense & National Security Systems, HF2 Financial Management, American Apparel, JetPay, and CCBC
PR Newswire - Tue Feb 17, 8:20AM CST
Editor Note: For more information about this release, please scroll to bottom.
APP: 0.65 (-0.03), GDEF: 10.43 (-0.05), JTPY: 3.24 (-0.01), CO: 6.42 (-0.05), HTWO: 9.70 (-0.11)

China Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2015 Financial Results
PR Newswire - Tue Feb 17, 6:00AM CST
China Cord Blood Corporation (NYSE: CO) (the "Company" today announced its plan to release its unaudited financial results for the third quarter and first nine months of fiscal 2015 on Wednesday, February 25, 2015, after market close in the US.
CO: 6.42 (-0.05)

Keep An Eye On China Cord Blood
Jack Banser - at Seeking Alpha - Tue Feb 10, 8:19AM CST

CO: 6.42 (-0.05)

China Cord Blood Corporation and Cord Blood Registry Enter into Strategic Collaboration
PR Newswire - Wed Jan 28, 7:00AM CST
China Cord Blood Corporation (CCBC, NYSE: CO), China's first and largest umbilical cord blood bank, and Cord Blood Registry® (CBR®), the world's largest newborn stem cell company, today entered into a memorandum of understanding regarding their strategic collaboration in China and the United States. The two prominent cord blood banks will share data on cord blood collection, processing and storage to advance international standards. The companies will also work together under the memorandum, to develop a family disease registry for CCBC's clients in China and jointly support newborn stem cell-related clinical trials in the U.S. and China.
CO: 6.42 (-0.05)

Cord Blood Registry and China Cord Blood Corporation Enter into Strategic Collaboration
PR Newswire - Wed Jan 28, 7:00AM CST
Cord Blood Registry® (CBR®), the world's largest newborn stem cell company, and China Cord Blood Corporation (CCBC [NYSE: CO]), China's first and largest umbilical cord blood bank, today entered into a memorandum of understanding regarding their strategic collaboration in China and the United States. The two prominent cord blood banks will share data on cord blood collection, processing and storage to advance international standards. The companies will also work together under the memorandum, to develop a family disease registry for CCBC's clients in China and jointly support newborn stem cell-related clinical trials in the U.S. and China.
CO: 6.42 (-0.05)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Nucor's Q3 2026 Earnings: Strong Growth Amid Steel Surge

Updated Category News Views 116

Nucor's Solid Third Quarter Performance Nucor Corporation is flexing its muscles, reporting a robust third quarter for 2026. With net earnings hitting $1.32 billion and a diluted earnings per share of $5.80, the steel giant has shown it can more than hold its ground in a competitive market. Compare that to last quarter's $1.16 billion - we're seeing serious momentum....

Continue Reading
Pacsun Finds Gear: 177% Sales Surge at F1 Austin!

Updated Category News Views 76

New Heights in Trackside Fashion Well, it looks like Pacsun's got a knack for making the Austin F1 scene as thrilling as the race itself, weaving fashion into the high-speed atmosphere. This year's Formula 1 United States Grand Prix in Austin brought a whopping 19% sales swell in 2026, marking a total sales increase of 177% since their initial 2023 Austin pop-up. Talk...

Continue Reading
NACCO Industries Preps for Q3 Results and Call

Updated Category News Views 0

Anticipation Builds for NACCO's Q3 Financial Insights From the streets of Cleveland, NACCO Industries is ramping up to release their third quarter financial results for 2026. Mark your calendars for November 4, just after the market packs up for the day. Now, isn't it something to watch how these earnings reports seem to become a spectacle all their own? Promising...

Continue Reading
Bank of America Faces Legal Battle Over Compliance Failures

Updated Category News Views 106

Another Day, Another Lawsuit Just when you thought the financial waters were calm, there's a storm brewing for Bank of America Corp. (NYSE: BAC). They've been slapped with a securities class action lawsuit that screams all kinds of regulatory and compliance failures. You’d think with all that cash flow, BAC could afford to run a tight ship. But apparently, they decided...

Continue Reading
Govee's Retro Holiday Lights: A Festive Nostalgia Trip

Updated Category News Views 69

Ah, the holidays—they're creeping up like a kid sneaking downstairs for a peek at their gifts. But it's not the gifts under the tree that brighten a room, it's those lights draping the tree itself. Enter Govee, bringing us back to that vintage glow we all remember from our childhoods. They've teamed up with Brady Tolbert, a design whiz who can make a living room look...

Continue Reading
Unlocking AI Edge with Workplace Data and Human Insight

Updated Category News Views 95

Insights from the SPS Report on AI and Workplace Data When data, AI, and human context play in harmony, businesses dance to a new tune. SPS has shed some light on this dynamic in their freshly minted report, "Turning Workplace Data into a Competitive Advantage." Now, anyone paying attention to the tech-driven evolution of business will see that merely piling up workplace...

Continue Reading
Sands China's Latest Move: A Bond Offering Twist

Updated Category News Views 74

Breaking Down Sands China's Bond Maneuver Today, we found out that Sands China is teeing up a fresh round of senior unsecured notes. Now, if that doesn't get your ticker flickin', maybe you're too used to market snoozefests. The folks at the helm of Sands China, a subsidiary under the mighty Las Vegas Sands Corp. (NYSE: LVS), are rolling out these USD-denominated notes...

Continue Reading
Tempo's Protein Max Meals: A High-Protein Revolution

Updated Category News Views 0

Packed Protein, Zero Hassle Every once in a while, something comes along in the food sector that changes the game. Tempo's Protein Max meals might just be it. Launching with a hefty 40 grams of protein in every serving, these meals promise a powerful punch for anyone who's serious about meeting their protein counts without spending hours in the kitchen. Two minutes flat...

Continue Reading
Beer B Que Music Festival: Hip-Hop, Dancehall & Brews

Updated Category News Views 67

A Melody and Brew-Infused South Florida Celebration Boy, if festivals were stocks, I'd have bought into the Beer B Que Music Festival years ago. This event, rolling into its seventh year, isn't just another line-up of artists—it feels like a genuine cultural reunion for folks in South Florida. You throw in some heavyweight names like Rick Ross and Kodak Black, plus the...

Continue Reading
Worldline Crowned as 2026 SPARK Matrix Leader

Updated Category News Views 51

Worldline's Journey to Leadership When you talk about the big dogs in payment services, Worldline’s name crops up for a reason. They've just snagged a top spot in the 2026 SPARK Matrix by the QKS Group, putting them in the limelight as a leader in Merchant Payment Platform technology. If you're in payments, this is worth a double take. The SPARK Matrix Breakdown The...

Continue Reading

Top 5 Most Recently Viewed Articles

Impressive Financial Growth Reported by Community Healthcare Trust

Updated Category News Views 99

Community Healthcare Trust Shows Strong Financial Performance Community Healthcare Trust Incorporated (NYSE: CHCT) has recently reported its financial results for the three-month period ending on December 31, 2024. The Company recorded a net income of approximately $1.8 million, which translates to about $0.04 per diluted common share. Furthermore, for the same period,...

Continue Reading
Celebrate Every Mini Win This Monday with DOVE Ice Cream

Updated Category News Views 423

Celebrate Every Mini Win This Monday with DOVE Ice Cream Getting through Mondays can be a challenge, but DOVE® Ice Cream is transforming this weekly hurdle into a delightful celebration. Introducing the #MiniWinMonday initiative, this campaign is designed to acknowledge and celebrate those small victories that often get overlooked. Whether it's completing a task or...

Continue Reading
Stocks and Financial Indicators Continue to Evolve Amid Changes

Updated Category News Views 236

Wall Street witnessed quite the spectacle back then, as both the Nasdaq Composite and the S&P 500 hit record-breaking closes. This surge was fueled by investor optimism amid those ongoing Fed policy discussions and economic indicators that seemed to change every minute. Market Peaks: Numbers Never Lie? The Nasdaq Composite increased about 0.6%, while the S&P 500 saw an...

Continue Reading
4TEEN4 Pharmaceuticals Commences Exciting Trial for Procizumab

Updated Category News Views 235

4TEEN4 Pharmaceuticals Initiates Trial for Procizumab 4TEEN4 Pharmaceuticals GmbH has reached an important milestone with the initiation of the PROCARD1 clinical trial, focusing on their monoclonal antibody, procizumab. This trial represents a significant step in treating cardiogenic shock, a critical condition resulting from severe circulatory failure. Shock is a serious...

Continue Reading
NVIDIA's Evo 2 AI System Reimagines Genetic Research Landscape

Updated Category News Views 302

NVIDIA's Introduction of Evo 2 for Advanced Genetic Research NVIDIA (NVDA) has unveiled an innovative artificial intelligence system called Evo 2, designed to enhance biological research capabilities. Transforming Genetics with AI Evo 2 rapidly analyzes and generates genetic code from varied organisms, significantly furthering advancements in genetics and medicine. NVIDIA...

Continue Reading